Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Licensing agreements    crawled time : 14:02    save search
Chinook Therapeutics Announces License Agreement with Morehouse School of Medicine for Development of Therapies in Kidney Diseases Disproportionately Affecting African Americans and Underserved Communities
Published: 2020-12-08 (Crawled : 14:02) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0 twitter stocktwits trandingview |
Health Technology
 | | O: 1.11% H: 1.6% C: -2.84%
license therapy disease kidney diseases kidney
SELLAS Life Sciences and 3D Medicines Announce Exclusive License Agreement for Development and Commercialization of Galinpepimut-S (GPS) and GPS+ in Greater China
Published: 2020-12-07 (Crawled : 14:02) - globenewswire.com
SLS | $1.525 0.33% 0.33% 1.8M twitter stocktwits trandingview |
Health Technology
 | | O: 8.81% H: 2.38% C: -12.14%
license china life science commercialization
Y-mAbs and Takeda Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) and Omburtamab in Israel
Published: 2020-12-04 (Crawled : 14:02) - globenewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
 | | O: 0.76% H: 1.13% C: 1.08%
YMAB | $15.15 1.0% 0.99% 470K twitter stocktwits trandingview |
Health Technology
 | | O: 0.24% H: 1.63% C: 0.92%
license israel distribution
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.